PVL Fundamental Analysis - PLASTIVALOIRE

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to PVL. PVL was compared to 66 industry peers in the Chemicals industry. PVL has a bad profitability rating. Also its financial health evaluation is rather negative. PVL is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year PVL has reported negative net income.

PVL had a positive operating cash flow in the past year.

In the past 5 years PVL reported 4 times negative net income.

In the past 5 years PVL always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of -6.04%, PVL is doing worse than 77.27% of the companies in the same industry.

Looking at the Return On Equity, with a value of -23.13%, PVL is doing worse than 80.30% of the companies in the same industry.

PVL has a worse Return On Invested Capital (1.38%) than 60.61% of its industry peers.

Measured over the past 3 years, the Average Return On Invested Capital for PVL is below the industry average of 7.02%.

		Industry Rank	Sector Rank
ROA	-6.04%
ROE	-23.13%
ROIC	1.38%

ROA(3y)-3.76%

ROA(5y)-2.43%

ROE(3y)-13.19%

ROE(5y)-8.49%

ROIC(3y)2.18%

ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 1.26%, PVL is doing worse than 63.64% of the companies in the same industry.

In the last couple of years the Operating Margin of PVL has declined.

PVL's Gross Margin of 48.03% is fine compared to the rest of the industry. PVL outperforms 69.70% of its industry peers.

PVL's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	1.26%
PM (TTM)	N/A
GM	48.03%

OM growth 3Y-24.59%

OM growth 5Y-25.32%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.37%

GM growth 5Y2.85%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PVL is destroying value.

Compared to 1 year ago, PVL has about the same amount of shares outstanding.

Compared to 5 years ago, PVL has about the same amount of shares outstanding.

Compared to 1 year ago, PVL has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.52, we must say that PVL is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 1.52, PVL is doing worse than 74.24% of the companies in the same industry.

A Debt/Equity ratio of 1.24 is on the high side and indicates that PVL has dependencies on debt financing.

PVL has a Debt to Equity ratio of 1.24. This is amonst the worse of the industry: PVL underperforms 86.36% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.24
Debt/FCF	N/A
Altman-Z	1.52

ROIC/WACC0.32

WACC4.3%

2.3 Liquidity

PVL has a Current Ratio of 1.33. This is a normal value and indicates that PVL is financially healthy and should not expect problems in meeting its short term obligations.

The Current ratio of PVL (1.33) is worse than 75.76% of its industry peers.

PVL has a Quick Ratio of 1.16. This is a normal value and indicates that PVL is financially healthy and should not expect problems in meeting its short term obligations.

With a Quick ratio value of 1.16, PVL perfoms like the industry average, outperforming 51.52% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.33
Quick Ratio	1.16

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

PVL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -175.68%.

The Revenue has decreased by -7.04% in the past year.

Measured over the past years, PVL shows a decrease in Revenue. The Revenue has been decreasing by -0.69% on average per year.

EPS 1Y (TTM)-175.68%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-80.95%

Revenue 1Y (TTM)-7.04%

Revenue growth 3Y1.28%

Revenue growth 5Y-0.69%

Sales Q2Q%-14.65%

3.2 Future

PVL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 58.74% yearly.

PVL is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.68% yearly.

EPS Next Y-1340%

EPS Next 2Y84.39%

EPS Next 3Y58.74%

EPS Next 5YN/A

Revenue Next Year-10.28%

Revenue Next 2Y-4.97%

Revenue Next 3Y-1.68%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PVL. In the last year negative earnings were reported.

A Price/Forward Earnings ratio of 13.56 indicates a correct valuation of PVL.

Compared to the rest of the industry, the Price/Forward Earnings ratio of PVL indicates a somewhat cheap valuation: PVL is cheaper than 69.70% of the companies listed in the same industry.

PVL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.18.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	13.56

4.2 Price Multiples

PVL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PVL is cheaper than 96.97% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	3.52

4.3 Compensation for Growth

PVL's earnings are expected to grow with 58.74% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y84.39%

EPS Next 3Y58.74%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for PVL!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PLASTIVALOIRE

EPA:PVL (10/21/2025, 11:14:13 AM)

1.918

-0.01 (-0.62%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)08-28 2025-08-28

Earnings (Next)11-17 2025-11-17/amc

Inst Owners1.03%

Inst Owner ChangeN/A

Ins Owners54.69%

Ins Owner ChangeN/A

Market Cap42.45M

Analysts45.71

Price Target1.43 (-25.44%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-9.68%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)10.56%

EPS NY rev (3m)4%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-0.29%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	13.56
P/S	0.06
P/FCF	N/A
P/OCF	2.22
P/B	0.22
P/tB	0.34
EV/EBITDA	3.52

EPS(TTM)-2.04

EYN/A

EPS(NY)0.14

Fwd EY7.37%

FCF(TTM)-0.08

FCFYN/A

OCF(TTM)0.86

OCFY44.97%

SpS31.79

BVpS8.81

TBVpS5.7

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.04%
ROE	-23.13%
ROCE	2.13%
ROIC	1.38%
ROICexc	1.74%
ROICexgc	2.14%
OM	1.26%
PM (TTM)	N/A
GM	48.03%
FCFM	N/A

ROA(3y)-3.76%

ROA(5y)-2.43%

ROE(3y)-13.19%

ROE(5y)-8.49%

ROIC(3y)2.18%

ROIC(5y)N/A

ROICexc(3y)2.53%

ROICexc(5y)N/A

ROICexgc(3y)3.11%

ROICexgc(5y)N/A

ROCE(3y)3.17%

ROCE(5y)N/A

ROICexcg growth 3Y-20.84%

ROICexcg growth 5Y-21.45%

ROICexc growth 3Y-19.92%

ROICexc growth 5Y-21.2%

OM growth 3Y-24.59%

OM growth 5Y-25.32%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.37%

GM growth 5Y2.85%

F-Score6

Asset Turnover0.94

Health

		Industry Rank	Sector Rank
Debt/Equity	1.24
Debt/FCF	N/A
Debt/EBITDA	4.82
Cap/Depr	50.56%
Cap/Sales	2.96%
Interest Coverage	0.97
Cash Conversion	38.12%
Profit Quality	N/A
Current Ratio	1.33
Quick Ratio	1.16
Altman-Z	1.52

F-Score6

WACC4.3%

ROIC/WACC0.32

Cap/Depr(3y)60.25%

Cap/Depr(5y)56.65%

Cap/Sales(3y)3.98%

Cap/Sales(5y)3.96%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-175.68%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-80.95%

EPS Next Y-1340%

EPS Next 2Y84.39%

EPS Next 3Y58.74%

EPS Next 5YN/A

Revenue 1Y (TTM)-7.04%

Revenue growth 3Y1.28%

Revenue growth 5Y-0.69%

Sales Q2Q%-14.65%

Revenue Next Year-10.28%

Revenue Next 2Y-4.97%

Revenue Next 3Y-1.68%

Revenue Next 5YN/A

EBIT growth 1Y-70.23%

EBIT growth 3Y-23.63%

EBIT growth 5Y-25.84%

EBIT Next Year687.32%

EBIT Next 3Y103.91%

EBIT Next 5YN/A

FCF growth 1Y53.59%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-28.16%

OCF growth 3Y-26.28%

OCF growth 5Y-7.25%

PLASTIVALOIRE (PVL.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens